Oska Pulse
Most affordable FDA-registered wearable PEMF for pain relief, with placebo-controlled clinical trial backing
REGISTERED
Registered with the FDA but NOT cleared or approved. Administrative listing only — no safety evaluation.
Key facts at a glance.
- Founded
- 2015
- Headquarters
- Carlsbad, California, USA
- Price range
- $399–$499
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $399 |
| 3-year total | $399 |
What the device does.
- + Wearable, palm-sized device
- + 4 fixed frequencies for cartilage, bone, blood flow, pain
- + 90 or 180 minute auto sessions
- + Battery powered, fully portable
- + Hands-free strap
- + FSA/HSA eligible
The trade-offs.
- + **Most affordable FDA-registered wearable PEMF for pain relief** ($399-499)
- + Placebo-controlled clinical trial backing — rare among consumer PEMF
- + Wearable palm-sized portable form factor
- + 4 fixed frequencies for cartilage, bone, blood flow, pain
- + 90 or 180 minute auto sessions
- + HSA / FSA eligible
- + Hands-free strap for ambulatory use
- − **Localized only** — not full-body mat coverage
- − No customization of frequencies
- − Very low intensity (typical for portable wearable PEMF)
- − Mixed user reviews on efficacy
- − FDA-registered not FDA-cleared (administrative listing)
Chronic pain sufferers, seniors, FSA/HSA buyers
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Oska Pulse is the affordable wearable PEMF specialist for pain relief — manufactured by Oska Wellness (founded 2015 in Carlsbad CA), with structural positioning targeting chronic pain sufferers, seniors, and FSA/HSA buyers wanting portable PEMF without full-body mat commitment. The product is palm-sized wearable with 4 fixed frequencies (cartilage, bone, blood flow, pain) at 90 or 180 minute auto sessions. Hands-free strap enables ambulatory use during normal activities.
The structural value claim is genuine within the wearable-pain-relief tier: at $399-499, Oska Pulse is the most affordable FDA-registered wearable PEMF in the consumer market (vs FlexPulse’s $1,290 portable-pocket form factor or HealthyLine $200-2,500 stationary mats). Placebo-controlled clinical trial backing is rare among consumer PEMF brands — most consumer PEMF marketing relies on general PEMF research literature without device-specific clinical evidence. HSA / FSA eligibility provides meaningful effective-cost reduction for users with Health Savings Account or Flexible Spending Account funds.
The structural editorial caveats are scope-related: localized only (palm-sized device covers limited treatment area per session — not full-body), no frequency customization (4 fixed presets), very low intensity (typical limitation of portable wearable PEMF — physics constraints on miniaturization), and mixed user reviews on efficacy (typical for PEMF category where individual response varies). For chronic pain sufferers wanting portable HSA-eligible affordable PEMF with placebo-controlled trial backing, Oska Pulse is structurally appropriate. For users wanting full-body coverage (HealthyLine, Healthy Wave, BioBalance), customization (Healthy Wave), or higher intensity (Pulse PEMF Centers), structurally better matches exist.
When Oska Pulse Makes Sense
Strong fit: Chronic pain sufferers wanting portable wearable PEMF; HSA / FSA-eligible buyers; senior consumers (simple interface); affordable entry-tier with clinical-trial backing.
Weaker fit: Full-body coverage needs (HealthyLine, Healthy Wave); customization preference (Healthy Wave); higher intensity (Pulse PEMF Centers); programmability (FlexPulse pocket-portable Pawluk-designed).
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| Oska Pulse | ~$399-499 |
| HSA / FSA-effective cost (~30% reduction) | ~$280-350 effective |
| 3-year ownership | ~$400-500 (or $280-350 HSA-effective) |
Compare: FlexPulse ($1,290 portable Pawluk-designed), HealthyLine ($200-2,500 multi-modality mats), BioBalance ($2,450 Pawluk-endorsed full-body), OMI PEMF ($499-1,499 budget full-body), Pulse PEMF Centers ($5K-22K clinical).
Verdict: Recommended
Oska Pulse earns a recommended verdict on the strength of its position as the most affordable FDA-registered wearable PEMF for pain relief ($399-499 vs $1,290+ for portable alternatives), placebo-controlled clinical trial backing rare among consumer PEMF, palm-sized wearable form factor with hands-free strap for ambulatory use, 4 fixed frequencies covering cartilage / bone / blood flow / pain, 90 or 180 minute auto sessions, and HSA / FSA eligibility providing effective-cost reduction.
For chronic pain sufferers wanting affordable portable HSA-eligible PEMF with placebo-controlled trial backing, Oska Pulse is structurally the leading consumer choice. For users wanting full-body coverage (HealthyLine, Healthy Wave, BioBalance), customization (Healthy Wave), higher intensity (Pulse PEMF Centers), or programmability (FlexPulse), structurally better-matched alternatives exist.
Changelog
- 2026-05-07: Initial review published based on Oska Pulse published specifications, placebo-controlled clinical trial documentation, HSA / FSA eligibility positioning, and aggregated user-report data.
What we'll measure on the bench.
- Protocol
- Gaussmeter at user-bench position
- Primary metric
- Peak magnetic field strength (µT)
- Pass threshold
- within ±20% of vendor spec
- Session shape
- 5 measurements across mat surface
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.